A study found that typical cholesterol exams could be missing an important indicator of heart disease risk in certain people.

Researchers from Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical ...

Rocket Pharmaceuticals, Inc.'s innovative therapies show promise after FDA setbacks. With potential $1B+ markets, RCKT offers ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

A cardiac surgery and heart failure team at the University of Michigan implanted a novel mechanical heart pump into a patient as part of a clinical trial that will compare it to the only device ...

WARRINGTON, Pa. - Windtree Therapeutics, Inc. (NASDAQ:WINT), a biotechnology firm specializing in the development of therapies for critical diseases and currently valued at $1.44 million market ...

As tools become more precise and non-invasive, doctors are able to diagnose and treat heart conditions with greater accuracy and efficiency.

Dr Swetha Bakhru, senior consultant of paediatrics, Rainbow Children’s Heart Institute, said, “Around 10 per cent of the CHD ...

Live regular Dr Xand Van Tulleken said people taking certain drugs needed to be cautious about eating a specific type of ...

Researchers at Johns Hopkins Medicine have discovered that a drug originally developed for Alzheimer’s disease, schizophrenia ...